CIK 0001289850
NURO NeuroMetrix, Inc.
Insider trading from SEC Form 4. Last filing May 5, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
6
with a Form 4 at this company
Signals
Open-market buys and sells at NeuroMetrix, Inc., scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 38 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 1, 2025 | Shai Gozani President and CEO | DDisposition to issuer Common Stock | -15,466 | - | - | 0 | May 5, 2025 |
| May 1, 2025 | Thomas T Higgins Senior Vice President, CFO | DDisposition to issuer Common Stock | -11,840 | - | - | 0 | May 5, 2025 |
| May 1, 2025 | Joshua Horowitz director | DDisposition to issuer Common Stock | -29,807 | - | - | 0 | May 5, 2025 |
| May 1, 2025 | Nancy E Katz director | DDisposition to issuer Common Stock | -7,602 | - | - | 0 | May 5, 2025 |
| May 1, 2025 | David Van Avermaete director | DDisposition to issuer Common Stock | -7,601 | - | - | 0 | May 5, 2025 |
| May 1, 2025 | David Goodman director | DDisposition to issuer Common Stock | -7,602 | - | - | 0 | May 5, 2025 |
| May 1, 2025 | David Goodman director | DDisposition to issuer Restricted Stock Unitderivative | -13,730 | - | - | 0 | May 5, 2025 |
| May 1, 2025 | Shai Gozani President and CEO | DDisposition to issuer Restricted Stock Unitderivative | -4,384 | - | - | 0 | May 5, 2025 |
| May 1, 2025 | Thomas T Higgins Senior Vice President, CFO | DDisposition to issuer Restricted Stock Unitderivative | -3,308 | - | - | 0 | May 5, 2025 |
| May 1, 2025 | Joshua Horowitz director | DDisposition to issuer Common Stockindirect: See footnote | -60,500 | - | - | 0 | May 5, 2025 |
| May 1, 2025 | Nancy E Katz director | DDisposition to issuer Restricted Stock Unitderivative | -13,730 | - | - | 0 | May 5, 2025 |
| May 1, 2025 | David Van Avermaete director | DDisposition to issuer Restricted Stock Unitderivative | -13,730 | - | - | 0 | May 5, 2025 |
| Apr 1, 2025 | Shai Gozani President and CEO | MOption exercise Common Stock | +625 | $4.41 | $2,756 | 15,544 | Apr 3, 2025 |
| Apr 1, 2025 | Thomas T Higgins Senior Vice President, CFO | MOption exercise Common Stock | +469 | $4.41 | $2,068 | 11,916 | Apr 3, 2025 |
| Apr 1, 2025 | Thomas T Higgins Senior Vice President, CFO | FTax withholding Common Stock | -76 | $4.41 | $335 | 11,840 | Apr 3, 2025 |
| Apr 1, 2025 | Shai Gozani President and CEO | FTax withholding Common Stock | -78 | $4.41 | $344 | 15,466 | Apr 3, 2025 |
| Apr 1, 2025 | Shai Gozani President and CEO | MOption exercise Restricted Stock Unitderivative | -625 | $4.41 | $2,756 | 3,750 | Apr 3, 2025 |
| Apr 1, 2025 | Thomas T Higgins Senior Vice President, CFO | MOption exercise Restricted Stock Unitderivative | -469 | $4.41 | $2,068 | 2,811 | Apr 3, 2025 |
| Feb 2, 2025 | Shai Gozani President and CEO | MOption exercise Common Stock | +636 | $4.31 | $2,741 | 14,998 | Feb 5, 2025 |
| Jan 1, 2025 | Thomas T Higgins Senior Vice President, CFO | MOption exercise Common Stock | +469 | $3.97 | $1,862 | 11,102 | Feb 5, 2025 |
| Feb 2, 2025 | Thomas T Higgins Senior Vice President, CFO | MOption exercise Common Stock | +498 | $4.31 | $2,146 | 11,529 | Feb 5, 2025 |
| Jan 1, 2025 | Shai Gozani President and CEO | MOption exercise Common Stock | +625 | $3.97 | $2,481 | 14,437 | Feb 5, 2025 |
| Jan 1, 2025 | Thomas T Higgins Senior Vice President, CFO | FTax withholding Common Stock | -71 | $3.97 | $282 | 11,031 | Feb 5, 2025 |
| Feb 2, 2025 | Shai Gozani President and CEO | FTax withholding Common Stock | -79 | $4.31 | $340 | 14,919 | Feb 5, 2025 |
| Feb 2, 2025 | Thomas T Higgins Senior Vice President, CFO | FTax withholding Common Stock | -82 | $4.31 | $353 | 11,447 | Feb 5, 2025 |
| Jan 1, 2025 | Shai Gozani President and CEO | FTax withholding Common Stock | -75 | $3.97 | $298 | 14,362 | Feb 5, 2025 |
| Jan 1, 2025 | Thomas T Higgins Senior Vice President, CFO | MOption exercise Restricted Stock Unitderivative | -469 | $3.97 | $1,862 | 3,280 | Feb 5, 2025 |
| Jan 1, 2025 | Shai Gozani President and CEO | MOption exercise Restricted Stock Unitderivative | -625 | $3.97 | $2,481 | 4,375 | Feb 5, 2025 |
| Feb 2, 2025 | Thomas T Higgins Senior Vice President, CFO | MOption exercise Restricted Stock Unitderivative | -498 | $4.31 | $2,146 | 497 | Feb 5, 2025 |
| Feb 2, 2025 | Shai Gozani President and CEO | MOption exercise Restricted Stock Unitderivative | -636 | $4.31 | $2,741 | 634 | Feb 5, 2025 |
| Feb 3, 2025 | Joshua Horowitz director | AGrant or award Common Stock | +369 | $0.00 | $0 | 23,807 | Feb 3, 2025 |
| Feb 3, 2025 | Joshua Horowitz director | AGrant or award Common Stock | +6,000 | $0.00 | $0 | 29,807 | Feb 3, 2025 |
| Nov 2, 2024 | Shai Gozani President & CEO | MOption exercise Common Stock | +636 | $4.00 | $2,544 | 13,854 | Nov 5, 2024 |
| Nov 2, 2024 | Thomas T Higgins Senior Vice President, CFO | MOption exercise Common Stock | +498 | $4.00 | $1,992 | 10,663 | Nov 5, 2024 |
| Nov 2, 2024 | Shai Gozani President & CEO | FTax withholding Common Stock | -42 | $4.00 | $168 | 13,812 | Nov 5, 2024 |
| Nov 2, 2024 | Thomas T Higgins Senior Vice President, CFO | FTax withholding Common Stock | -30 | $4.00 | $120 | 10,633 | Nov 5, 2024 |
| Nov 2, 2024 | Shai Gozani President & CEO | MOption exercise Restricted Stock Unitderivative | -636 | $4.00 | $2,544 | 1,270 | Nov 5, 2024 |
| Nov 2, 2024 | Thomas T Higgins Senior Vice President, CFO | MOption exercise Restricted Stock Unitderivative | -498 | $4.00 | $1,992 | 995 | Nov 5, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- David Goodmandirector
- Shai GozaniPresident and CEO
- Thomas T HigginsSenior Vice President, CFO
- Joshua Horowitzdirector
- Nancy E Katzdirector
- David Van Avermaetedirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.